JJ
John Patrick Shannon Jr
See RemarksDirector

John Patrick Shannon Jr insider trades: Xeris Biopharma Holdings (XERS) stock buys and sales

See Remarks, Xeris Biopharma Holdings Last trade Jan 5, 2026 30 Form 4 filings
$350K
Sold, last 12 months
2 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2014
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where John reports to the SEC

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 5, 2026XERS↓ Sell$176K
Nov 13, 2025XERS↓ Sell$173K
Nov 17, 2023XERS↑ Buy$50K
Nov 12, 2021XERS↑ Buy$210K
May 13, 2020XERS↑ Buy$78K
May 8, 2020XERS↑ Buy$25K
Feb 14, 2020XERS↑ Buy$50K
Aug 12, 2014DRTX↑ Buy$41K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other XERS insiders

Open-market trades in the last 12 months

About John Patrick Shannon Jr's insider trades

John Patrick Shannon Jr is See Remarks at Xeris Biopharma Holdings (XERS). Since Aug 12, 2014, John has reported 6 open-market purchases worth $454K and 2 sales worth $350K on SEC Form 4. In the last 12 months: 2 sales ($350K).

Their filings also include grants and awards (16 filings), shares withheld for taxes (6 filings), option exercises (2 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every XERS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.